Merck KGaA (MRK) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.020x

Based on the latest financial reports, Merck KGaA (MRK) has a cash flow conversion efficiency ratio of 0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€605.00 Million ≈ $707.31 Million USD) by net assets (€30.29 Billion ≈ $35.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Merck KGaA for the company's overall valuation and market capitalisation.

Merck KGaA - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Merck KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Merck KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Merck KGaA ranked by their cash flow conversion efficiency. Explore how high is Merck KGaA's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Tower Semiconductor Ltd
TA:TSEM
0.058x
Arca Continental S.A.B. de C.V
MX:AC
0.051x
Evolution Mining Ltd
AU:EVN
0.222x
Grace Fabric Technology Co Ltd
SHG:603256
0.028x
Krung Thai Bank Public Company Limited
BK:KTB
0.286x
Fubon Financial Holding Co Ltd Pref B
TW:2881B
0.005x
Huatai Securities Co Ltd
SHG:601688
0.170x
Helvetia Holding AG
SW:HELN
0.064x

Annual Cash Flow Conversion Efficiency for Merck KGaA (2002–2025)

The table below shows the annual cash flow conversion efficiency of Merck KGaA from 2002 to 2025. View current stock price of Merck KGaA for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €28.66 Billion
≈ $33.51 Billion
€3.93 Billion
≈ $4.60 Billion
0.137x -10.29%
2024-12-31 €29.99 Billion
≈ $35.06 Billion
€4.59 Billion
≈ $5.36 Billion
0.153x +8.13%
2023-12-31 €26.75 Billion
≈ $31.28 Billion
€3.78 Billion
≈ $4.42 Billion
0.141x -13.64%
2022-12-31 €26.00 Billion
≈ $30.40 Billion
€4.26 Billion
≈ $4.98 Billion
0.164x -24.02%
2021-12-31 €21.42 Billion
≈ $25.04 Billion
€4.62 Billion
≈ $5.40 Billion
0.216x +5.49%
2020-12-31 €17.02 Billion
≈ $19.89 Billion
€3.48 Billion
≈ $4.06 Billion
0.204x +28.15%
2019-12-31 €17.91 Billion
≈ $20.94 Billion
€2.86 Billion
≈ $3.34 Billion
0.159x +23.82%
2018-12-31 €17.23 Billion
≈ $20.15 Billion
€2.22 Billion
≈ $2.59 Billion
0.129x -32.82%
2017-12-31 €14.07 Billion
≈ $16.44 Billion
€2.70 Billion
≈ $3.15 Billion
0.192x +6.95%
2016-12-31 €14.05 Billion
≈ $16.43 Billion
€2.52 Billion
≈ $2.94 Billion
0.179x +4.95%
2015-12-31 €12.86 Billion
≈ $15.03 Billion
€2.20 Billion
≈ $2.57 Billion
0.171x -25.52%
2014-12-31 €11.80 Billion
≈ $13.80 Billion
€2.71 Billion
≈ $3.16 Billion
0.229x +14.03%
2013-12-31 €11.07 Billion
≈ $12.94 Billion
€2.23 Billion
≈ $2.60 Billion
0.201x -15.30%
2012-12-31 €10.41 Billion
≈ $12.18 Billion
€2.47 Billion
≈ $2.89 Billion
0.237x +95.95%
2011-12-31 €10.49 Billion
≈ $12.27 Billion
€1.27 Billion
≈ $1.49 Billion
0.121x -29.51%
2010-12-31 €10.37 Billion
≈ $12.13 Billion
€1.78 Billion
≈ $2.08 Billion
0.172x +19.24%
2009-12-31 €9.51 Billion
≈ $11.12 Billion
€1.37 Billion
≈ $1.60 Billion
0.144x +35.42%
2008-12-31 €9.62 Billion
≈ $11.25 Billion
€1.02 Billion
≈ $1.20 Billion
0.106x -24.10%
2007-12-31 €8.69 Billion
≈ $10.16 Billion
€1.22 Billion
≈ $1.42 Billion
0.140x -34.22%
2006-12-31 €3.81 Billion
≈ $4.45 Billion
€811.70 Million
≈ $948.96 Million
0.213x -3.11%
2005-12-31 €3.33 Billion
≈ $3.89 Billion
€732.50 Million
≈ $856.37 Million
0.220x +11.57%
2004-12-31 €2.89 Billion
≈ $3.38 Billion
€570.90 Million
≈ $667.44 Million
0.197x -38.07%
2003-12-31 €2.36 Billion
≈ $2.76 Billion
€752.40 Million
≈ $879.63 Million
0.318x +55.07%
2002-12-31 €2.05 Billion
≈ $2.40 Billion
€421.70 Million
≈ $493.01 Million
0.205x --

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic
Market Cap
$19.62 Billion
€16.78 Billion EUR
Market Cap Rank
#1305 Global
#291 in Germany
Share Price
€129.85
Change (1 day)
-1.22%
52-Week Range
€102.80 - €147.50
All Time High
€220.61
About

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for re… Read more